Longbow Finance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Sell
9,917
-926
-9% -$946K 1.52% 23
2026
Q1
$9.97M Buy
10,843
+3,422
+46% +$3.47M 1.81% 15
2025
Q4
$7.98M Sell
7,421
-5,895
-44% -$5.64M 1.35% 24
2025
Q3
$10.2M Sell
13,316
-5,637
-30% -$4.19M 1% 37
2025
Q2
$14.8M Sell
18,953
-11,721
-38% -$9.11M 1.58% 14
2025
Q1
$25.3M Buy
30,674
+12,421
+68% +$10.3M 3.03% 9
2024
Q4
$14.1M Buy
18,253
+864
+5% +$715K 1.54% 15
2024
Q3
$15.4M Sell
17,389
-6,488
-27% -$5.83M 1.64% 13
2024
Q2
$21.6M Sell
23,877
-1,328
-5% -$1.06M 2.23% 9
2024
Q1
$19.6M Buy
25,205
+10,662
+73% +$7.59M 1.98% 10
2023
Q4
$8.48M Sell
14,543
-2,802
-16% -$1.64M 0.86% 44
2023
Q3
$9.32M Sell
17,345
-59
-0.3% -$30.4K 1.12% 32
2023
Q2
$8.16M Buy
+17,404
New +$7.3M 0.95% 41

Other funds holding LLY

Longbow Finance's LLY Position: Q2 2026 in Review

Longbow Finance reduced its Eli Lilly (LLY) stake by 8.5% in Q2 2026, selling an estimated $946K and leaving 9,917 shares worth $11.9M. The position accounts for 1.52% of the portfolio, ranked #23.

Longbow Finance first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $25.3M in Q1 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Longbow Finance held 9,917 shares of Eli Lilly worth $11.9M as of Q2 2026.
  • Longbow Finance sold 926 Eli Lilly shares in Q2 2026, an estimated $946K.
  • Eli Lilly made up 1.52% of Longbow Finance's portfolio in Q2 2026, its #23 holding.
  • Longbow Finance first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Longbow Finance's Eli Lilly position peaked at $25.3M in Q1 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Longbow Finance's 13F filing for Q2 2026, filed 29 Jul 2026.